Bausch Health Companies (BHC) Net Cash Flow Growth (5y) (2014 - 2026)
Powered by 
Analysis
Bausch Health Companies (BHC) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.54% |
| Mar 31, 2026 | -15.58% |
| Dec 31, 2025 | 35.23% |
| Sep 30, 2025 | -50.63% |
| Jun 30, 2025 | 96.57% |
| Mar 31, 2025 | 45.07% |
| Dec 31, 2024 | -27.37% |
| Sep 30, 2024 | 40.95% |
| Jun 30, 2024 | -27.14% |
| Mar 31, 2024 | -39.94% |
| Dec 31, 2023 | 21.66% |
| Sep 30, 2023 | 8.19% |
| Jun 30, 2023 | 26.33% |
| Mar 31, 2023 | -21.49% |
| Dec 31, 2022 | 15.48% |
| Sep 30, 2022 | -80.28% |
| Jun 30, 2022 | -22.04% |
| Mar 31, 2022 | -11.96% |
| Dec 31, 2021 | 42.34% |
| Sep 30, 2021 | 52.04% |